Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Journal article

Hamdy FC. et al, (2023), New England Journal of Medicine

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment

Journal article

Donovan JL. et al, (2023), NEJM Evidence

Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshop.

Journal article

Beard DJ. et al, (2021), Health Technol Assess, 25, 1 - 52

A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.

Journal article

Erickson A. et al, (2021), Eur Urol Oncol, 4, 358 - 369

Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy.

Journal article

Rajakumar T. et al, (2021), Future Oncol, 17, 1083 - 1095

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.

Journal article

Huynh-Le M-P. et al, (2021), Nat Commun, 12

The effect of sample size on polygenic hazard models for prostate cancer.

Journal article

Karunamuni RA. et al, (2020), Eur J Hum Genet, 28, 1467 - 1475

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.

Journal article

Bailey MH. et al, (2020), Nat Commun, 11

A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.

Journal article

Huynh-Le M-P. et al, (2020), Cancer Epidemiol Biomarkers Prev, 29, 1731 - 1738

Load More